Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

9.75
Delayed Data
As of 4:00pm ET
 -0.19 / -1.91%
Today’s Change
6.40
Today|||52-Week Range
19.23
-24.59%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close9.94
Today’s open9.96
Day’s range9.55 - 10.11
Volume138,442
Average volume (3 months)120,865
Market cap$181.4M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)+63.66%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.32

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.06-0.92%
ZFGNZafgen Inc-0.26-3.92%
ARGSArgos Therapeutics I...-0.85-11.99%
NBRVNabriva Therapeutics...+0.01+0.12%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers

Search for Jobs